252 related articles for article (PubMed ID: 32525789)
21. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
23. Nuclear imaging for cardiac amyloidosis.
Noordzij W; Glaudemans AW; Longhi S; Slart RH; Lorenzini M; Hazenberg BP; Rapezzi C
Heart Fail Rev; 2015 Mar; 20(2):145-54. PubMed ID: 25424887
[TBL] [Abstract][Full Text] [Related]
24. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy of [
Rosengren S; Skibsted Clemmensen T; Tolbod L; Granstam SO; Eiskjær H; Wikström G; Vedin O; Kero T; Lubberink M; Harms HJ; Flachskampf FA; Baron T; Carlson K; Mikkelsen F; Antoni G; Frost Andersen N; Hvitfeldt Poulsen S; Sörensen J
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1337-1347. PubMed ID: 32417330
[TBL] [Abstract][Full Text] [Related]
26. Current role of imaging techniques in cardiac amyloidosis.
Pudis M; Bastarrika Alemañ G
Med Clin (Barc); 2023 Feb; 160(3):121-128. PubMed ID: 36543710
[TBL] [Abstract][Full Text] [Related]
27. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic imaging of cardiac amyloidosis.
Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
[TBL] [Abstract][Full Text] [Related]
29. Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.
Di Nunzio D; Recupero A; de Gregorio C; Zito C; Carerj S; Di Bella G
Curr Cardiol Rep; 2019 Feb; 21(2):7. PubMed ID: 30747298
[TBL] [Abstract][Full Text] [Related]
30. Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers.
Hotta M; Minamimoto R; Awaya T; Hiroe M; Okazaki O; Hiroi Y
Radiographics; 2020; 40(7):2029-2041. PubMed ID: 32976061
[TBL] [Abstract][Full Text] [Related]
31. Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?
Gagliardi C; Tabacchi E; Bonfiglioli R; Diodato S; Nanni C; Guidalotti P; Lorenzini M; Lodi F; Milandri A; Rapezzi C; Fanti S
J Nucl Cardiol; 2017 Apr; 24(2):746-749. PubMed ID: 26976144
[TBL] [Abstract][Full Text] [Related]
32. Novel Tracers for the Imaging of Cardiac Amyloidosis.
Shetty M; Malhotra S
J Nucl Med Technol; 2023 Jun; 51(2):120-124. PubMed ID: 37192820
[TBL] [Abstract][Full Text] [Related]
33. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of
Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
[TBL] [Abstract][Full Text] [Related]
35. Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis-A New Dimension of Molecular Imaging.
Gherghe M; Lazar AM; Sterea MC; Spiridon PM; Motas N; Gales LN; Coriu D; Badelita SN; Mutuleanu MD
J Cardiovasc Dev Dis; 2023 May; 10(6):. PubMed ID: 37367407
[TBL] [Abstract][Full Text] [Related]
36. Potential Cardiac Amyloid PET/CT Imaging Targets for Differentiating Immunoglobulin Light Chain From Transthyretin Amyloidosis.
Schindler TH; Sharma M; Valenta I; Imperiale A; Dilsizian V
Curr Cardiol Rep; 2021 Jun; 23(7):76. PubMed ID: 34081210
[TBL] [Abstract][Full Text] [Related]
37. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
[TBL] [Abstract][Full Text] [Related]
38. Cardiac Amyloidosis Detected on Imaging of Patients with Heart Failure.
Roginić S; Vinter O; Trbušić M; Roginić M; Ćatić Ćuti E
Am J Case Rep; 2020 Nov; 21():e926290. PubMed ID: 33175723
[TBL] [Abstract][Full Text] [Related]
39. Molecular Imaging of Cardiac Amyloidosis.
Masri A; Bukhari S; Eisele YS; Soman P
J Nucl Med; 2020 Jul; 61(7):965-970. PubMed ID: 32482792
[TBL] [Abstract][Full Text] [Related]
40. Misconceptions and Facts About Cardiac Amyloidosis.
Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
